Original language | English (US) |
---|---|
Pages (from-to) | 818-819 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 401 |
Issue number | 10379 |
DOIs | |
State | Published - Mar 11 2023 |
ASJC Scopus subject areas
- General Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: The Lancet, Vol. 401, No. 10379, 11.03.2023, p. 818-819.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - The need for appropriate language in the debate on medicalisation of pregnancy
AU - Cluver, Catherine
AU - de Groot, Christianne
AU - Mol, Ben W.
AU - Murphy, Kellie E.
AU - Norman, Jane E.
AU - Pacagnella, Rodolfo
AU - Palmer, Kirsten
AU - Poon, Liona C.
AU - Rolnik, Daniel L.
AU - Spong, Catherine Y.
AU - Stock, Sarah J.
AU - Thangaratinam, Shakila
AU - Tong, Stephen
AU - Verhoeven, Corine
AU - Vuong, Lan N.
AU - Walker, Sue P.
AU - Xiaohua, Liu
N1 - Funding Information: CdG is President of the Dutch Society of Obstetrics & Gynecology. BWM reports an investigator grant from the National Health and Medical Research Council (NHMRC; GN1176437); consultancy fees at an hourly rate for ObsEva, Merck KGaA, Guerbet, iGenomix, and Merck; and travel support from Merck KGaA. JEN is Deputy Vice-Chancellor and Provost at the University of Nottingham and a non-executive Director of a UK National Health Service Trust, and reports funding from UK charities and the UK Government to conduct clinical trials into improving outcomes for pregnant women and their babies. KP reports an investigator grant from the NHMRC (GNT2009765). SJS declares grants from the National Institute of Healthcare Research Health Technology and Assessment, Wellcome Trust, Medical Research Council, The Chief Scientist Office of Scotland, and Tommy's Charity, all paid to her institution; consulting fees on pre-term birth treatments to Natera; honoraria for educational speaking from Hologic, all paid to her institution; participation in the National Institute of Healthcare Research Health Technology and Assessment data monitoring committee and trial steering committee in the past 36 months; and a leadership role in the Trustee of Sands charity. All other authors declare no competing interests.
PY - 2023/3/11
Y1 - 2023/3/11
UR - http://www.scopus.com/inward/record.url?scp=85150225751&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150225751&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(23)00125-3
DO - 10.1016/S0140-6736(23)00125-3
M3 - Letter
C2 - 36906342
AN - SCOPUS:85150225751
SN - 0140-6736
VL - 401
SP - 818
EP - 819
JO - The Lancet
JF - The Lancet
IS - 10379
ER -